Closure of Biomedical Innovation Fund I

Wellington Management, one of the world’s largest independent investment management firms, today announced the final close of the oversubscribed Wellington Biomedical Innovation Fund I. The Fund will invest in private biotechnology companies that are focused on drug discovery and development, and are seeking capital to advance their scientific programs.

PRESS RELEASE

Wellington Management Announces Close of Biomedical Innovation Fund I at $393M

BOSTON, HONG KONG, LONDON, November 18, 2019 – Wellington Management (“Wellington” or the “Firm”), one of the world’s largest independent investment management firms, today announced the final close of the oversubscribed Wellington Biomedical Innovation Fund I (“Fund”).

The Fund will invest in private biotechnology companies focused on drug discovery and development, and seeking capital to advance their scientific programs.

Bob Deresiewicz, MD, Senior Managing Director at Wellington, said, “Biotechnology represents an exciting investment area, driven by an explosion in fundamental biomedical knowledge and a growing ability of companies to deploy that knowledge in the service of breakthrough drug discovery. We pursue an evidence-based approach to investing, seeking to leverage our biomedical, scientific, and industry expertise to identify promising assets that could meaningfully advance medical practice.”

Chris Kirk, the President of Wellington Alternative Investments, added, “This new sector-focused fund is the next step in expanding our private investment capabilities as we look for new opportunities to create long-term value for our investors. We believe our portfolio companies will benefit from partnering with Wellington and our extensive team of tenured industry analysts, who bring sector-level insights and public market expertise in support of their strategic growth plans.”

The close of Wellington’s Biomedical Innovation Fund I expands the Firm’s private investment platform, which now includes both health care and late stage growth funds totaling $2.7 billion. The funds’ global investor base includes public and private pension plans, insurance companies, corporations, and family offices.

About Wellington Management

Tracing its history to 1928, Wellington Management is one of the world’s largest independent investment management firms, serving as a trusted adviser to over 2,200 institutional and private clients located in more than 60 countries and managing over USD 1 trillion of assets.*

Wellington offers comprehensive investment management capabilities that span nearly all segments of the global capital markets. The firm’s only business is investment management and its mission is to exceed the investment objectives and service expectations of its clients worldwide. Wellington’s solutions draw on a robust body of proprietary research and a collaborative culture that encourages independent thought and healthy debate.

For more information, visit wellington.com.

*For Wellington Management group of companies as at 30 September 2019.

Media
Prosek Partners (on behalf of Wellington Management)
Abby McAleney
[email protected]
(646) 503-6025

RECOMMENDED FOR YOU

The future of payments
We profile the innovations fueling the next stage of disruption in the payments industry.
April 2021
The future of payments
,
The digital transformation of financial services
We highlight the fintech innovations driving the digitization and disruption of financial services.
April 2021
The digital transformation of financial services
,
Why Europe offers a robust hunting ground for small caps
Portfolio Manager Anna Lundén offers her local perspective on Europe, highlighting the inefficiencies created over time by the outperformance of small-cap companies vs large-cap companies.
April 2021
Why Europe offers a robust hunting ground for small caps
,
EM small caps: Hidden gems in plain sight?
Our team makes the case for strategically investing in EM small caps and for employing an actively managed approach to this underutilized asset class.
March 2021
EM small caps: Hidden gems in plain sight?
,
<em>Investment bytes – Asia tech</em><br><span>Faster computation with smaller, more powerful computer chips</span>
We explore the technology fueling the next stage of computer chip innovation.
March 2021
Investment bytes – Asia tech
Faster computation with smaller, more powerful computer chips
,
APAC Investment Forum 2021
Wellington specialists offer their views on the key themes transforming the investment opportunity set today.
March 2021
APAC Investment Forum 2021
,
Investing in innovation: Disruption is everywhere
We outline our definition of innovation and answer questions about our views on the breadth and depth of the innovation opportunity, how we identify and compare disruptive companies across industries, and the importance of robust research capabilities — including a private-equity mindset and strong ESG expertise.
March 2021
Investing in innovation: Disruption is everywhere
,
Equity factor extremes and the case for quality in value and growth
As equity factor leadership continues to defy conventional wisdom, Fundamental Factor Team members Gregg Thomas and Katrina Price see evidence of excessive expectations in today’s market and make a case for quality in both value and growth stocks.
March 2021
Equity factor extremes and the case for quality in value and growth
,